Glycyrrhetinic acid modified chlorambucil prodrug for hepatocellular carcinoma treatment based on DNA replication and tumor microenvironment
- Resource Type
- Article
- Source
- In
Colloids and Surfaces B: Biointerfaces December 2022 220 - Subject
- Language
- ISSN
- 0927-7765